Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP.

Autor: Morales AE; Department of Medicine, Weill Cornell Medicine, New York, New York, United States of America., Gumenick R; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, United States of America., Genovese CM; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, United States of America., Jang YY; Department of Medicine, Weill Cornell Medicine, New York, New York, United States of America., Ouedraogo A; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, United States of America., Ibáñez de Garayo M; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, United States of America., Pannellini T; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, United States of America., Patel S; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, United States of America., Bott ME; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, United States of America., Alvarez J; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, United States of America., Mun SS; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America., Totonchy J; School of Pharmacy, Chapman University, Irvine, California, United States of America., Gautam A; Department of Allergy and Immunology, Icahn School of Medicine, New York, New York, United States of America., Delgado de la Mora J; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, United States of America., Chang S; Cornell University, Ithaca, New York, United States of America., Wirth D; Model Systems for Infection and Immunity, Helmholtz Centre for Infection Research Braunschweig, Germany., Horenstein M; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, United States of America., Dao T; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America., Scheinberg DA; Department of Medicine, Weill Cornell Medicine, New York, New York, United States of America.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America., Rubinstein PG; Section of Hematology/Oncology, John H. Stroger Jr Hospital of Cook County (Cook County Hospital), Ruth M. Rothstein Core Center, University of Illinois, Chicago, Illinois, United States of America., Semeere A; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda., Martin J; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States of America., Godfrey CC; Office of the Global AIDS Coordinator, Department of State, Washington, DC, United States of America., Moser CB; Center for Biostatistics in AIDS Research, Harvard T H Chan School of Public Health, Boston, Massachusetts, United States of America., Matining RM; Center for Biostatistics in AIDS Research, Harvard T H Chan School of Public Health, Boston, Massachusetts, United States of America., Campbell TB; Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, United States of America., Borok MZ; Department of Internal Medicine, University of Zimbabwe, Harare, Zimbabwe., Krown SE; Memorial Sloan Kettering Cancer Center (emerita), New York, New York, United States of America., Cesarman E; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, United States of America.

Publikováno v: PLoS pathogens [PLoS Pathog] 2024 Jan 08; Vol. 20 (1), pp. e1011881. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2024).